119 related articles for article (PubMed ID: 32712019)
1. Knockout of the Tachykinin Receptor 1 in the Mdr2
Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019
[TBL] [Abstract][Full Text] [Related]
2. Prolonged administration of a secretin receptor antagonist inhibits biliary senescence and liver fibrosis in Mdr2 -/- mice.
Wu N; Zhou T; Carpino G; Baiocchi L; Kyritsi K; Kennedy L; Ceci L; Chen L; Wu C; Kundu D; Barupala N; Franchitto A; Onori P; Ekser B; Gaudio E; Francis H; Glaser S; Alpini G
Hepatology; 2023 Jun; 77(6):1849-1865. PubMed ID: 36799446
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression.
Patsenker E; Popov Y; Stickel F; Jonczyk A; Goodman SL; Schuppan D
Gastroenterology; 2008 Aug; 135(2):660-70. PubMed ID: 18538673
[TBL] [Abstract][Full Text] [Related]
4. Endothelin Receptor-A Inhibition Decreases Ductular Reaction, Liver Fibrosis, and Angiogenesis in a Model of Cholangitis.
Owen T; Carpino G; Chen L; Kundu D; Wills P; Ekser B; Onori P; Gaudio E; Alpini G; Francis H; Kennedy L
Cell Mol Gastroenterol Hepatol; 2023; 16(4):513-540. PubMed ID: 37336290
[TBL] [Abstract][Full Text] [Related]
5. Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis.
Meadows V; Marakovits C; Ekser B; Kundu D; Zhou T; Kyritsi K; Pham L; Chen L; Kennedy L; Ceci L; Wu N; Carpino G; Zhang W; Isidan A; Meyer A; Owen T; Gaudio E; Onori P; Alpini G; Francis H
Am J Physiol Gastrointest Liver Physiol; 2023 Jan; 324(1):G60-G77. PubMed ID: 36410025
[TBL] [Abstract][Full Text] [Related]
6. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases.
Zhang J; Lyu Z; Li B; You Z; Cui N; Li Y; Li Y; Huang B; Chen R; Chen Y; Peng Y; Fang J; Wang Q; Miao Q; Tang R; Gershwin ME; Lian M; Xiao X; Ma X
Hepatology; 2023 Jul; 78(1):10-25. PubMed ID: 36799463
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the
Fuchs CD; Sroda N; Scharnagl H; Gupta R; Minto W; Stojakovic T; Liles JT; Budas G; Hollenback D; Trauner M
JHEP Rep; 2023 Nov; 5(11):100874. PubMed ID: 37841639
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosis.
Stiedl P; McMahon R; Blaas L; Stanek V; Svinka J; Grabner B; Zollner G; Kessler SM; Claudel T; Müller M; Mikulits W; Bilban M; Esterbauer H; Eferl R; Haybaeck J; Trauner M; Casanova E
Hepatology; 2015 Feb; 61(2):613-26. PubMed ID: 25179284
[TBL] [Abstract][Full Text] [Related]
9. Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice.
Nishio T; Hu R; Koyama Y; Liang S; Rosenthal SB; Yamamoto G; Karin D; Baglieri J; Ma HY; Xu J; Liu X; Dhar D; Iwaisako K; Taura K; Brenner DA; Kisseleva T
J Hepatol; 2019 Sep; 71(3):573-585. PubMed ID: 31071368
[TBL] [Abstract][Full Text] [Related]
10. Telomere dysfunction promotes cholangiocyte senescence and biliary fibrosis in primary sclerosing cholangitis.
Jalan-Sakrikar N; Anwar A; Yaqoob U; Gan C; Lagnado AB; Wixom AQ; Jurk D; Huebert RC
JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37707950
[TBL] [Abstract][Full Text] [Related]
11. Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.
Tabibian JH; O'Hara SP; Trussoni CE; Tietz PS; Splinter PL; Mounajjed T; Hagey LR; LaRusso NF
Hepatology; 2016 Jan; 63(1):185-96. PubMed ID: 26044703
[TBL] [Abstract][Full Text] [Related]
12. Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1.
Zhuang Y; Ortega-Ribera M; Thevkar Nagesh P; Joshi R; Huang H; Wang Y; Zivny A; Mehta J; Parikh SM; Szabo G
Hepatology; 2024 Apr; 79(4):752-767. PubMed ID: 37725754
[TBL] [Abstract][Full Text] [Related]
13. TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver.
Weber SN; Bohner A; Dapito DH; Schwabe RF; Lammert F
PLoS One; 2016; 11(7):e0158819. PubMed ID: 27391331
[TBL] [Abstract][Full Text] [Related]
14. GLP-2 Improves Hepatic Inflammation and Fibrosis in Mdr2
Fuchs CD; Claudel T; Mlitz V; Riva A; Menz M; Brusilovskaya K; Haller F; Baumgartner M; Königshofer P; Unger LW; Sjöland W; Scharnagl H; Stojakovic T; Busslinger G; Reiberger T; Marschall HU; Trauner M
Cell Mol Gastroenterol Hepatol; 2023; 16(5):847-856. PubMed ID: 37572734
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin reverses ductular reaction and hepatic fibrosis in a rodent model of cholestasis.
Petrescu AD; Grant S; Williams E; Frampton G; Reinhart EH; Nguyen A; An S; McMillin M; DeMorrow S
Sci Rep; 2020 Sep; 10(1):16024. PubMed ID: 32994489
[TBL] [Abstract][Full Text] [Related]
16. Beta-lapachone ameliorates the progression of primary sclerosing cholangitis pathogenesis in rodent models.
Woo SH; Lee SH; Moon SJ; Han J; Seo KS; Lee H; Lee CH; Hwang JH
Life Sci; 2024 Jan; 337():122342. PubMed ID: 38092141
[TBL] [Abstract][Full Text] [Related]
17. Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice.
Latasa MU; Gil-Puig C; Fernández-Barrena MG; Rodríguez-Ortigosa CM; Banales JM; Urtasun R; Goñi S; Méndez M; Arcelus S; Juanarena N; Recio JA; Lotersztajn S; Prieto J; Berasain C; Corrales FJ; Lecanda J; Avila MA
PLoS One; 2010 Dec; 5(12):e15690. PubMed ID: 21209952
[TBL] [Abstract][Full Text] [Related]
18. Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout mice.
Hintermann E; Tondello C; Fuchs S; Bayer M; Pfeilschifter JM; Taubert R; Mollenhauer M; Elferink RPJO; Manns MP; Christen U
J Autoimmun; 2024 Apr; 146():103229. PubMed ID: 38653165
[TBL] [Abstract][Full Text] [Related]
19. Molecular Insights of Cholestasis in MDR2 Knockout Murine Liver Organoids.
Blázquez-García I; Guerrero L; Cacho-Navas C; Djouder N; Millan J; Paradela A; Carmona-Rodríguez L; Corrales FJ
J Proteome Res; 2024 Apr; 23(4):1433-1442. PubMed ID: 38488493
[TBL] [Abstract][Full Text] [Related]
20. Antagonistic effects of the cytotoxic molecules granzyme B and TRAIL in the immunopathogenesis of sclerosing cholangitis.
Kellerer M; Javed S; Casar C; Will N; Berkhout LK; Schwinge D; Krebs CF; Schramm C; Neumann K; Tiegs G
Hepatology; 2024 Mar; ():. PubMed ID: 38441998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
